Biotechnology
Dole Sunshine Company Partners With EDB New Ventures To Create A New Business In Specialty Ingredients Developed From Fruit Side-streams
SINGAPORE, Oct. 18, 2021 /PRNewswire/ -- Dole Sunshine Company (DSC) is partnering the Singapore Economic Development Board (EDB) for its new corporate venture, Dole Specialty Ingredients (DSI). This new venture will focus on sourcing and transforming fruit side streams and unutilised fruit parts...
2021-10-18 09:00
2484
UPL Announces Long-term Collaboration With Chr. Hansen To Develop And Commercialize Microbial Solutions For Sustainable Agriculture
- UPL is the largest manufacturer and distributor of biosolutions worldwide, fifth-largest agribusiness globally. - Chr. Hansen is the owner of one of the world's largest commercial collections of bacteria, with more than 28,000 strains - The biosolutions market set to grow to $10bn* USD by 2025...
2021-10-16 05:04
4166
Novavax to Participate in World Vaccine Congress Europe
GAITHERSBURG, Md., Oct. 16, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that Vivek Shinde, M.D., Vice President, Clinical Development, will deliver a...
2021-10-16 04:39
4288
CellOrigin secured a new round of investment for developing its globally proprietary iPSC-CAR-Macrophage technology platform
HANGZHOU, China, Oct. 15, 2021 /PRNewswire/ -- On Oct. 11th, 2021, CellOrigin Inc. released data about its second generation of iPSC-CAR-Macrophage which has a genetically integrated secondary signal to confer controlled CAR-iMac polarization, in the 5th International Conference of IGC China, 202...
2021-10-15 20:50
1500
Antengene to Present Data of Its PD-L1/4-1BB Bispecific Antibody ATG-101 and ERK1/2 Inhibitor ATG-017 at SITC 2021
SHANGHAI and HONG KONG, Oct. 15, 2021 /PRNewswire/ -- The 36th Annual Meeting of the Society for Immunotherapy for Cancer (SITC 2021) will take place in Washington, D.C., United States, on November 10-14, 2021. The SITC's annual meeting is the world's largest gathering in the field of immuno-oncol...
2021-10-15 13:33
2688
International Biopharma Industry Week Shanghai 2021 Opens
SHANGHAI, Oct. 15, 2021 /PRNewswire/ -- On October 11, the International Biopharma Industry Week Shanghai 2021, under the guidance of the Shanghai Biomedical Industry Development Leading Group, the inaugural International Biopharma Industry Week Shanghai (IBIWS) is co-hosted by Shanghai Biomedica...
2021-10-15 12:22
3188
Qiming's Portfolio Company Abbisko Lists on Main Board of HKEx
SHANGHAI, Oct. 15, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Abbisko (SEHK:2256), a clinical-stage biopharmaceutical company, listed on the main board of the Hong Kong Stock Exchange onOctober 13. The issue price isHK$ 12.46 per share, representing a market cap of HK$ 8.753 ...
2021-10-15 12:00
3525
GV20 Oncotherapy Completes Series B Financing to Advance Pipeline into the Clinic and Expand Immuno-Oncology Drug Discovery Platform
SHANGHAI, Oct. 14, 2021 /PRNewswire/ -- GV20 Oncotherapy, a biotechnology company with unique expertise in novel target identification and antibody drug discovery in immuno-oncology, today announced the completion of its Series B financing. This round of financing was led by Coatue Management,...
2021-10-14 23:55
1609
Gan & Lee Pharmaceuticals Concludes Phase 3 Studies of Gan & Lee Insulin Glargine (GL-GLA)
BEIJING and BRIDGEWATER, N.J., Oct. 14, 2021 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee) (Shanghai: 603087.SH), is pleased to announce the completion of two randomized, multicenter, phase 3 studies that compare proposed biosimilar Gan & Lee insulin ...
2021-10-14 20:46
2832
Evaxion Biotech Lauded by Frost & Sullivan for Helping Develop Highly Targeted Therapies with Its AI Immunology Platforms
The company's PIONEER™, EDEN™, and RAVEN™ platforms mimic the human immune system to simplify the drug development process for a range of diseases LONDON, Oct. 14, 2021 /PRNewswire/ -- Based on its recent analysis of the European AI-enabled drug discovery market,Frost & Sullivan recognizes Evaxio...
2021-10-14 19:30
1423
BioAgilytix Closes Acquisition of Australia-based 360biolabs®
Following final government approval, 360biolabs, a BioAgilytix company, adds world-class virology & immunology expertise and LC/MS/MS small molecule capabilities to the company, enabling support of bioanalytical services across all geographies and development stages DURHAM, N.C., Oct. 14, 2021 /...
2021-10-14 19:00
1541
BioAgilytix Closes Acquisition of Australia-based 360biolabs®
Following final government approval, 360biolabs, a BioAgilytix company, adds world-class virology & immunology expertise and LC/MS/MS small molecule capabilities to the company, enabling support of bioanalytical services across all geographies and development stages DURHAM, N.C., Oct. 14, 2021 ...
2021-10-14 19:00
1476
One-shot Sputnik Light vaccine (first component of the Sputnik V vaccine) demonstrates 70% efficacy against infection with the Delta variant during the first three months after vaccination, Gamaleya Center analysis shows
* The vaccine is more than 75% effective among subjects under the age of 60. Sputnik Light also provides much higher efficacy against severe disease and hospitalizations. * Sputnik Light has demonstrated a superior efficacy compared with some two-shot vaccines, which have shown a major decli...
2021-10-13 20:30
5022
I-Mab Advances Late-stage Development of Its Differentiated CD38 Antibody Felzartamab (TJ202) in China
* Completed patient enrollment in phase 3 registrational trial of felzartamab in combination with lenalidomide for second-line treatment of multiple myeloma (MM) * Felzartamab for MM third-line treatment is on track for BLA submission in Q4 2021 * New IND application for combination of felz...
2021-10-13 20:00
1338
Gilead Sciences Partners with the International AIDS Society to Champion Stigma-free HIV Care Services in Asia and Latin America
SINGAPORE, Oct. 13, 2021 /PRNewswire/ -- Gilead Sciences, Inc. today announced
its partnership with IAS - the International AIDS Society - to expand theMe &
My Healthcare Provider campaign
2021-10-13 13:00
1684
AUM Biosciences announces closing of USD $27Million in a "Series A" Round of funding to advance its clinical stage pipeline of precision and targeted cancer therapies
SINGAPORE, Oct. 12, 2021 /PRNewswire/ -- AUM Biosciences (AUM) today announced the successful completion of USD$27 million series A funding round. This will fuel AUM's vision of developing a world class biotech pipeline focused on drugging what many consider as the undruggable targets, as well ...
2021-10-13 02:30
1496
Vitality International - Pioneering Algorithm Calculates The Number Of Years Individuals Can Expect To Live In Good Health
- Research shows number of years people are spending in ill health is increasing, due to the rising prevalence of chronic diseases, driven by unhealthy lifestyles - Experts call for focus on healthspan, the quality of life, alongside lifespan, the quantity of life, citing significant economic an...
2021-10-12 22:54
2130
Merck Completes New Viral Vector Contract Development Manufacturing Facility for Gene Therapy
* Expansion in Carlsbad, California, USA, doubles production capacity to support commercialization and industrialization of viral vectors * Investment serves customers in addressing larger patient populations with new curative treatments * Enables suspension production of viral vectors up to...
2021-10-12 21:00
2754
Emmaus Life Sciences Acquires Key Intellectual Property Rights to Novel IRAK4 Inhibitor From Kainos Medicine
Agreement Expands on the Companies' Collaboration for the Preclinical Development of Potential Anti-Cancer Therapies TORRANCE, Calif., Oct. 12, 2021 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle ce...
2021-10-12 20:23
2261
NeoPlex (TM) HPV29 Detection, a new molecular detection kit from Genematrix, acquires European CE-IVD certification
* Real-time PCR-based human papillomavirus (HPV) detection product is launched. * Simultaneous HPV detection and genotyping of 29 HPV types are available. PANGYO,South Korea, Oct. 12, 2021 /PRNewswire/ -- Genematrix (KRX 109820), specialized in real-time PCR based molecular diagnostics, annou...
2021-10-12 16:00
1246
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
8288
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7685